EMA Drug Approvals Tracker
Every EU marketing authorisation from the last 12 months - new medicines, biosimilars and generics approved centrally through the European Medicines Agency - plus CHMP positive opinions still awaiting a European Commission decision.
Latest EU marketing authorisations
| Authorised | Medicine | Type | Marketing Authorisation Holder |
|---|---|---|---|
| 12 Nov 2026 | Zeydovio 2 clinical trials → | New Medicine | Zealand Pharma A/S |
| 12 Nov 2026 | Sepalna 2 clinical trials → | New Medicine | |
| 12 Nov 2026 | Inijaq 28 clinical trials → | Generic | Gedeon Richter Plc. |
| 12 Nov 2026 | Povofortay 8 clinical trials → | New Medicine | Incyte Biosciences Distribution B.V. |
| 12 Nov 2026 | Ruxolitinib Zentiva 71 clinical trials → | Generic | Zentiva k.s. |
| 22 Oct 2026 | Lynavoy | New MedicineOrphan | GlaxoSmithKline Trading Services Limited |
| 25 Sep 2026 | Cavoley 17 clinical trials → | Biosimilar | CuraTeQ Biologics s.r.o |
| 21 Sep 2026 | Nezglyal | New MedicineOrphan | Minoryx Therapeutics S.L. |
| 18 Sep 2026 | Tafamidis Accord | Generic | Accord Healthcare S.L.U. |
| 18 Sep 2026 | Ruxolitinib Viatris | Generic | Viatris Limited |
| 18 Sep 2026 | Susvimo 14 clinical trials → | New Medicine | Roche Registration GmbH |
| 18 Sep 2026 | Icotyde 10 clinical trials → | New Medicine | Janssen-Cilag International |
| 18 Sep 2026 | Zokovea | New Medicine | Shionogi B.V. |
| 28 Aug 2026 | Denosumab Ascend 24 clinical trials → | Biosimilar | Ascend GmbH |
| 20 Aug 2026 | Hopledo 2 clinical trials → | New Medicine | Zambon SpA |
| 20 Aug 2026 | Daybu | New MedicineOrphan | Acadia Pharmaceuticals B.V. |
| 20 Aug 2026 | Aujemflu | New Medicine | Seqirus Netherlands B.V. |
| 24 Jul 2026 | Colchicine Agepha Pharma 47 clinical trials → | New Medicine | Agepha Pharma s.r.o. |
| 20 Jul 2026 | Etcamah 13 clinical trials → | New Medicine | AstraZeneca AB |
| 15 Jul 2026 | Jascayd 7 clinical trials → | New Medicine | Boehringer Ingelheim International GmbH |
| 15 Jul 2026 | Liraglutide STADA 7 clinical trials → | New Medicine | STADA Arzneimittel AG |
| 15 Jul 2026 | Ablymico 7 clinical trials → | New Medicine | STADA Arzneimittel AG |
| 15 Jul 2026 | Vislyfa 14 clinical trials → | Biosimilar | Lupin Europe GmbH |
| 15 Jul 2026 | Vijoice 22 clinical trials → | New MedicineOrphan | Novartis Europharm Limited |
| 15 Jul 2026 | Boey | New Medicine | AbbVie Limited |
| 30 Jun 2026 | Itvisma | New Medicine | Novartis Europharm Limited |
| 19 Jun 2026 | Palbociclib Viatris 78 clinical trials → | Generic | Viatris Limited |
| 19 Jun 2026 | Cenrifki | New Medicine | Sanofi Winthrop Industrie |
| 19 Jun 2026 | Rexatilux 14 clinical trials → | Biosimilar | Intas Third Party Sales 2005 S.L. |
| 19 Jun 2026 | Redemplo 2 clinical trials → | New MedicineOrphan | Arrowhead Pharmaceuticals Ireland Limited |
| 29 May 2026 | Bopediat 15 clinical trials → | New Medicine | Proveca Pharma Limited |
| 29 May 2026 | Imdylltra 27 clinical trials → | New MedicineOrphan | Amgen Europe B.V. |
| 29 May 2026 | Zepzelca 17 clinical trials → | New MedicineOrphan | Pharma Mar S.A. |
| 28 May 2026 | Adstiladrin 3 clinical trials → | New MedicineATMP | Ferring Pharmaceuticals A/S |
| 21 May 2026 | Joenja 3 clinical trials → | New MedicineOrphan | Pharming Technologies B.V. |
| 06 May 2026 | Bysumlog | Biosimilar | Sandoz GmbH |
| 27 Apr 2026 | Dazparda 4 clinical trials → | Biosimilar | Sandoz GmbH |
| 27 Apr 2026 | Onerji 2 clinical trials → | New Medicine | Tanabe Pharma GmbH |
| 27 Apr 2026 | Xolremdi | New MedicineOrphan | Norgine B.V. |
| 27 Apr 2026 | Tuyory 75 clinical trials → | Biosimilar | Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.) |
| 27 Apr 2026 | Zandoriah 5 clinical trials → | Biosimilar | CinnaGen Co Unipessoal LDA |
| 23 Apr 2026 | Poherdy 92 clinical trials → | Biosimilar | Organon N.V. |
| 23 Apr 2026 | Palsonify | New MedicineOrphan | Crinetics Pharmaceuticals Europe GmbH |
| 23 Apr 2026 | Fubelv 11 clinical trials → | Biosimilar | Biosimilar Collaborations Ireland Limited |
| 23 Apr 2026 | Rhapsido 21 clinical trials → | New Medicine | Novartis Europharm Limited |
| 20 Apr 2026 | mCombriax | New Medicine | Moderna Biotech Spain, S.L. |
| 20 Apr 2026 | Ojemda 6 clinical trials → | New MedicineOrphan | Ipsen Pharma |
| 15 Apr 2026 | Enflonsia | New Medicine | Merck Sharp Dohme Limited |
| 30 Mar 2026 | Supemtek | New Medicine | Sanofi Winthrop Industrie |
| 26 Mar 2026 | Kygevvi | New MedicineOrphanPRIME | UCB Pharma |
| 26 Mar 2026 | Kayshild 137 clinical trials → | New Medicine | Novo Nordisk A/S |
| 26 Mar 2026 | Fylrevy | New Medicine | Gedeon Richter Plc. |
| 26 Mar 2026 | Ilumira | New Medicine | Shine Europe B.V. |
| 24 Mar 2026 | Rezurock 7 clinical trials → | New MedicineOrphan | Sanofi Winthrop Industrie |
| 16 Feb 2026 | Anktiva | New Medicine | Immunitybio Ireland Limited |
| 12 Feb 2026 | mNexspike | New Medicine | Moderna Biotech Spain, S.L. |
| 12 Feb 2026 | Myqorzo 3 clinical trials → | New Medicine | Cytokinetics (Ireland) Limited |
| 12 Feb 2026 | Exdensur 9 clinical trials → | New Medicine | GlaxoSmithKline Trading Services Limited |
| 10 Feb 2026 | Gotenfia 6 clinical trials → | Biosimilar | Stada Arzneimittel AG |
| 10 Feb 2026 | Ranluspec 14 clinical trials → | Biosimilar | Lupin Europe GmbH |
| 19 Jan 2026 | Aqneursa | New MedicineOrphan | Intrabio Ireland Limited |
| 19 Jan 2026 | Dawnzera 2 clinical trials → | New Medicine | Otsuka Pharmaceutical Netherlands B.V. |
| 09 Jan 2026 | Ondibta 5 clinical trials → | Biosimilar | Sandoz GmbH |
| 09 Jan 2026 | Waskyra | New MedicineOrphanATMP | Fondazione Telethon ETS |
| 09 Jan 2026 | VacPertagen | New Medicine | BioNet Europe |
| 09 Jan 2026 | Inluriyo 10 clinical trials → | New Medicine | Eli Lilly Nederland B.V. |
| 08 Jan 2026 | Teduglutide Viatris 2 clinical trials → | Generic | Viatris Limited |
| 08 Jan 2026 | Teizeild 7 clinical trials → | New MedicinePRIME | Sanofi Winthrop Industrie |
| 08 Jan 2026 | Osqay 24 clinical trials → | Biosimilar | Theramex Ireland Limited |
| 08 Jan 2026 | Austedo | New Medicine | Teva GmbH |
| 08 Jan 2026 | GalenVita | New Medicine | Curium Romania S.R.L. |
| 22 Dec 2025 | Wayrilz 10 clinical trials → | New MedicineOrphan | Sanofi B.V. |
| 28 Nov 2025 | Imaavy 11 clinical trials → | New Medicine | Janssen Cilag International NV |
| 24 Nov 2025 | Kyinsu 9 clinical trials → | New Medicine | Novo Nordisk A/S |
| 21 Nov 2025 | Svariya (previously Rivaroxaban Koanaa) 51 clinical trials → | Generic | PGF Pharma International d.o.o. |
CHMP positive opinions awaiting EC decision
| Opinion | Medicine | Type | Applicant |
|---|---|---|---|
| 12 Nov 2026 | Aumseqa | New Medicine | SFL Pharmaceuticals Deutschland GmbH |
| 12 Nov 2026 | Baxfendy 3 clinical trials → | New Medicine | AstraZeneca AB |
| 12 Nov 2026 | Donrafylix 4 clinical trials → | Biosimilar | Kuraci |
| 12 Nov 2026 | Fondaparinux sodium Evumed | Generic | Evumed Limited |
| 12 Nov 2026 | Garzulys 4 clinical trials → | Biosimilar | Sciencepharma Sp. z o.o |
| 12 Nov 2026 | Ruxolitinib Krka 71 clinical trials → | Generic | KRKA tovarna zdravil d.d. Novo mesto |
| 12 Nov 2026 | Zybrivo 208 clinical trials → | New Medicine | Fortvita Biologics (Ireland) Limited |
| 15 Oct 2026 | Fovlussea 14 clinical trials → | Biosimilar | Accord Healthcare S.L.U. |
| 15 Oct 2026 | Neuzafy 17 clinical trials → | Biosimilar | CuraTeQ Biologics (Malta) Limited |
| 15 Oct 2026 | Foundayo 18 clinical trials → | New Medicine | Eli Lilly Nederland B.V. |
| 15 Oct 2026 | Kizfizo 107 clinical trials → | New MedicineOrphan | ORPHELIA Pharma |
| 15 Oct 2026 | Yuviwel 2 clinical trials → | New MedicineOrphan | Ascendis Pharma Growth Disorders A/S |
| 15 Oct 2026 | Rasonque | New MedicineOrphan | Revolution Medicines Netherlands B.V. |
| 17 Sep 2026 | Adcomfo 12 clinical trials → | Biosimilar | Advanz Pharma Limited |
| 17 Sep 2026 | Frehemgo | New Medicine | Novo Nordisk A/S |
| 17 Sep 2026 | Lifyorli 5 clinical trials → | New MedicineOrphan | Corcept Therapeutics Netherlands B.V. |
| 17 Sep 2026 | Gevalka 11 clinical trials → | New Medicine | SFL Pharmaceuticals Deutschland GmbH |
| 17 Sep 2026 | Klygefa | New Medicine | Alexion Europe |
| 17 Sep 2026 | VaxRabeo | New Medicine | Sanofi Winthrop Industrie |
| 23 Jul 2026 | Evlarco 6 clinical trials → | New Medicine | A. Menarini International Licensing S.A. |
| 23 Jul 2026 | Lyrokaul 4 clinical trials → | New Medicine | LIB Therapeutics B.V. |
| 23 Jul 2026 | Ubeslo 6 clinical trials → | New Medicine | A. Menarini International Licensing S.A. |
| 23 Jul 2026 | Riociguat Accord 2 clinical trials → | Generic | Accord Healthcare S.L.U. |
| 25 Jun 2026 | Nylaspeg 17 clinical trials → | Biosimilar | Qilu Pharma Spain S.L. |
| 25 Jun 2026 | Onswik | New Medicine | Eli Lilly Nederland B.V. |
| 30 Jan 2025 | Skojoy 43 clinical trials → | Biosimilar | Amgen Technology (Ireland) UC |
A CHMP positive opinion is the scientific recommendation of the EMA's Committee for Medicinal Products for Human Use. The European Commission normally issues the legally binding marketing authorisation within 67 days of the opinion.
Source: European Medicines Agency medicines data - centrally authorised human medicines only; nationally authorised products are not included. Compare the US market in our FDA Approvals Tracker and FDA Recall Tracker, see the EU Clinical Trials Tracker for the trials behind these approvals, or cross-reference the Irish market in the Irish Medicines Database.